Randomized, Multinational, Study Of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2016
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms AFFIRM
- 18 Apr 2016 Results published in the Annals of Oncology
- 22 Mar 2012 This trial is recruting in United Kingdom.
- 01 Mar 2012 Actual patient number (268) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History